TWI292761B - C-14 oxidation of morphine derivatives - Google Patents
C-14 oxidation of morphine derivatives Download PDFInfo
- Publication number
- TWI292761B TWI292761B TW91115230A TW91115230A TWI292761B TW I292761 B TWI292761 B TW I292761B TW 91115230 A TW91115230 A TW 91115230A TW 91115230 A TW91115230 A TW 91115230A TW I292761 B TWI292761 B TW I292761B
- Authority
- TW
- Taiwan
- Prior art keywords
- formula
- derivative
- patent application
- morphine
- group
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
1292761 五、發明説明() 1 (請先閱讀背面之注意事項再填寫本頁) 本發明關於1 4 一羥基降嗎啡酮(14-hydroxynormorphinone )衍生物之製備方法,也關於製備降 經二氫嗎啡酮(nor oxymor phone)之新合成途徑’以及在該 途徑中之新中間物。 降羥二氫嗎啡酮爲製造重要之藥用類鴉片(如:納特 酮(naltrexone )和納洛酮)的關鍵中間物。一般用於製造 此種類鴉片之起始物質爲鴉片鹼,由此物質可以很容易地 合成類鴉片。由於鴉片鹼之供應有限,但對其之需求持續 增加,因此便產生許多替代方法來製備1 4 -羥基嗎啡衍 生物。見,如:EP 〇,158,476, US 5,922,876,及其中所列舉之參考資料。 還有,爲了排除對(製備)鴉片鹼之需要,庫柏,等 之(四面體 5 5 ( 1 9 9 9 ) ,11429 — 11436 ;W 0 00/6 6 5 88)最近說明一種用於從可待因 經濟部智慧財產局員工消費合作社印製 酮(codeinone)製備1 4 —經基可待因酮的氧化方法,其 係在室溫下,利用C 〇 ( 0 A c ) 3做爲金屬氧化劑,在醋 酸中氧化,而產量爲5 1%。其它氧化條件與金屬氧化劑 ,如··在其它條件下之Co (〇Ac)3、FeCl3、 C ο ( 0 A c ) 2與數種輔氧化劑之組合,R u〇4、 Μ η (〇A c ) 3、C u (〇A c ) 2,等,經證明在根據 庫柏之方法中並非很有效。 且不管庫柏之發現爲何,令人驚訝的是現已發現在從 式I I I所示之化合物製造式I V所示之1 4 一羥基降嗎 啡酮的方法中’當反應係在溫和鹼之存在下,且使用氧或 本纸張尺度適用中國國家標準(CNS ) A4規格(2l〇x297公楚] -4- 1292761 1¾ 9t>- A7 B7 五、發明説明( 2 空氣做爲輔氧化劑時鈷(I I )鹽類可做爲有效之氧化劑 。因此,本發明關於式I V所示之1 4 —羥基降嗎啡酮衍 生物的製備方法1292761 V. INSTRUCTIONS (1) (Please read the note on the back and fill out this page.) The present invention relates to a process for the preparation of a 14-hydroxynormorphinone derivative, and also to the preparation of dihydromorphine A new synthetic pathway for the oxymor phone and a new intermediate in this pathway. Hydroxymorpholone is a key intermediate in the manufacture of important pharmaceutical opioids such as naltrexone and naloxone. The starting material commonly used in the manufacture of this type of opium is opiate, from which substances can be easily synthesized into opioids. Since the supply of opiates is limited, but their demand continues to increase, many alternative methods have been developed to prepare 14-hydroxymorphine derivatives. See, for example, EP 〇, 158, 476, US 5, 922, 876, and references cited therein. Also, in order to eliminate the need for (preparation) of opiates, Cooper, et al. (tetrahedron 5 5 (1 9 9 9 ), 11429-11436; W 0 00/6 6 5 88) recently described a Codeinone, Ministry of Economic Affairs, Intellectual Property Office, Staff Cooperatives, Codeinone Preparation 1 4 - The oxidation of ketoconin, which uses C 〇 ( 0 A c ) 3 as a metal at room temperature The oxidant, oxidized in acetic acid, yielded 51%. Other oxidation conditions and metal oxidants, such as Co (〇Ac) 3, FeCl3, C ο ( 0 A c ) 2 and several auxiliary oxidants under other conditions, R u〇4, Μ η (〇A c) 3, C u (〇A c ) 2, etc., proved to be not very effective in the method according to Cooper. And regardless of Cooper's findings, it is surprisingly found in the process for the production of 14-hydroxynormorphones of formula IV from the compounds of formula III 'when the reaction is in the presence of a mild base And use oxygen or this paper scale to apply Chinese National Standard (CNS) A4 specification (2l〇x297 public Chu) -4- 1292761 13⁄4 9t>- A7 B7 V. Description of invention (2 Air as co-oxidant cobalt (II) Salts can be used as effective oxidizing agents. Therefore, the present invention relates to a method for preparing a 14-hydroxynormorphone derivative represented by formula IV.
IV 其包含將式I I I所示之化合物IV which comprises a compound of the formula I I I
(請先閲讀背面之注意事項再填寫本頁) 經濟邹智慧財產局員工消費合作社印製 III 與鈷(I I )氧化劑,在溫和鹼及做爲輔氧化劑之空 氣或氧的存在下進行反應; 其中1^爲(1 一 7 C )烷基,其隨意地被一或多種如 下群體所取代:氯(如:1 ,1 ,1 一三氯乙基)、丁烯 基、乙烯基、苄基、苯基或萘基; 且R2爲苄基,或被一或多個(1 一6 C )烷氧基團所 取代的苄基,或被一或多個鹵素所取代之苄基。 本發明之氧化方法爲一種具優良產量的有效方法,當 與庫柏等所描述之方法相比時,其產量有顯著之改良。 根據本發明,鈷(;[〗)氧化劑可從鈷(I I )鹽類 之範圍(如:CoF2、C0CI2、CoBr2、 c 0 ( I I )硫酸鹽、C ο ( I I )硝酸鹽、C ο ( i i )酷關、(:o(I I)丙酸鹽,等及其混合物)中選出 本紙張尺度適用中國國家標準(CNS ) A4規格(210X29*7公釐) -5- 1292761 Δ7 … ·_Β7_ 五、發明説明(3) (請先閲讀背面之注意事項再填寫本頁) 。在本發明方法中之較佳氧化劑爲Co (〇Ac) 2,且較 佳之輔氧化劑爲空氣。本氧化法之反應混合物爲一異質系 統;該氧化劑僅有少量溶解在所用之有機溶劑。只要該系 統爲異質的,則所使用之鈷(I I )量並不需非常嚴格, 且熟習此項技藝人士會知道如何選擇其足夠量。該輔氧化 劑係經由將其通氣入溶液中,且一邊攪拌溶液,來引入該 反應混合物內。 本領域之技術熟習人士知道何種型式之鹼爲溫和鹼, 然而,較佳之鹼爲醋酸鈉、醋酸鉀、磷酸鈉和磷酸鉀。最 佳者爲醋酸鈉。 較合適的爲,1^係(1 一 7C)烷基,且以乙基爲最 佳者。在R2方面,苄基爲最佳者。 根據本發明之氧化方法係在適合溶解此型化合物之有 機溶劑中進行,以(1 - 4 C )醇類或其混合物爲較佳之 溶劑,尤以乙醇爲更佳者。 經濟邹智慈財產局8工消費合作社印製 反應溫度通常較室溫爲高,且可根據所使用之溶劑的 沸點來選擇。然而,該溫度可能不能高過約1 0 0 °C,以 使溶液中保持足夠的氧氣。 在(1 一 7C)烷基、(1 — 6C)烷氧基及(1 一 4C)醇等詞中,該烷基團爲各具丄至了,1至6或1至 4個碳原子之側鏈型或無側鏈的烷基團,如··甲基、乙基 、異丙基、第三一丁基、庚基、等。 式I I I所示之化合物可藉由本領域所熟知的方法來 製備。較合適的爲,該式III化合物之製備方法包含將 本纸掁尺度適用中國國家標準(CNS ) A4規格(21〇X29*7公釐) -6- 1292761 A7 1¾ 办 P_B7 五、發明説明(」 4 式I I所示之嗎啡衍生物(Please read the note on the back and then fill out this page.) Economic Zou Intellectual Property Bureau employee consumption cooperative printed III and cobalt (II) oxidant, reacted in the presence of mild alkali and air or oxygen as auxiliary oxidant; 1 is a (1-7C)alkyl group which is optionally substituted with one or more of the following groups: chlorine (eg, 1,1,1-trichloroethyl), butenyl, vinyl, benzyl, Phenyl or naphthyl; and R 2 is benzyl, or benzyl substituted by one or more (1 - 6 C ) alkoxy groups, or benzyl substituted by one or more halogens. The oxidizing method of the present invention is an effective method with excellent yield, and its yield is significantly improved when compared with the method described by Cooper et al. According to the present invention, the cobalt (;[]) oxidizing agent may be in the range of cobalt (II) salts (eg, CoF2, COCI2, CoBr2, c0(II) sulfate, Cο(II) nitrate, C ο (ii) ) Cool paper, (:o(II) propionate, etc. and its mixture) The paper size is selected according to Chinese National Standard (CNS) A4 specification (210X29*7 mm) -5-1292761 Δ7 ... ·_Β7_ DESCRIPTION OF THE INVENTION (3) (Please read the note on the back side and then fill out this page.) The preferred oxidizing agent in the process of the present invention is Co (〇Ac) 2, and preferably the auxiliary oxidizing agent is air. The reaction mixture of the present oxidation method Is a heterogeneous system; the oxidant is only dissolved in a small amount in the organic solvent used. As long as the system is heterogeneous, the amount of cobalt (II) used does not need to be very strict, and those skilled in the art will know how to select it. The auxiliary oxidant is introduced into the reaction mixture by aerating it into the solution and agitating the solution. Those skilled in the art will know which type of base is a mild base, however, the preferred base is acetic acid. Sodium, potassium acetate, phosphorus Sodium and potassium phosphate. The most preferred one is sodium acetate. Suitably, 1^ is a (1-7C) alkyl group, and ethyl is preferred. In terms of R2, benzyl is the best. The oxidation method of the invention is carried out in an organic solvent suitable for dissolving the compound of the type, and the (1 - 4 C) alcohol or a mixture thereof is preferred as the solvent, especially ethanol. The economic Zou Zhici Property Bureau 8 workers consumption cooperative The printing reaction temperature is usually higher than room temperature and can be selected depending on the boiling point of the solvent used. However, the temperature may not be higher than about 100 ° C to maintain sufficient oxygen in the solution. In the terms of 7C)alkyl, (1-6C)alkoxy, and (1-4C)alcohol, the alkyl group is a side chain of each having from 1 to 6 or 1 to 4 carbon atoms. Or a side chain-free alkyl group such as methyl, ethyl, isopropyl, tert-butyl, heptyl, etc. The compound of formula III can be prepared by methods well known in the art. Suitably, the method for preparing the compound of formula III comprises applying the paper size to the Chinese National Standard (CNS) A4 specification ( 21〇X29*7 mm) -6- 1292761 A7 13⁄4 Office P_B7 V. Invention Description (" 4 Formula I I morphine derivative
(請先聞讀背面之注意事項再填寫本頁) 經由反應來與一可有效氧化烯丙基之羥基團的氧化劑 接觸,以形成酮基,此處,可製備出式I I I所示之嗎啡 酮化合物。較合適的爲,該氧化劑爲重鉻酸鈉。R i宜爲乙 基。R2以苄基爲最佳者。 本發明之新方法可以很方便地用來製備降羥二氫嗎啡 酮。因此,本發明另一方面係關於降羥二氫嗎啡酮之製備 方法,其包含一反應步驟,其中將式I I I·所示之嗎啡酮 化合物氧化成式I V所示之1 4 -羥基降嗎啡酮衍生物。 尤其是,本方法還包含將式I I所示之嗎啡衍生物氧化成 如上述之式I I I所示的化合物。 更特別的是一種降羥二氫嗎啡酮的製備方法,其包含 下列步驟: (a )將具式I之嗎啡(Please read the precautions on the back and fill out this page.) By reacting with an oxidizing agent which can effectively oxidize the hydroxyl group of the allyl group to form a ketone group, here, the morphinone of the formula III can be prepared. Compound. More suitably, the oxidizing agent is sodium dichromate. R i is preferably an ethyl group. R2 is preferably the benzyl group. The novel process of the present invention can be conveniently used to prepare hydroxymorpholone. Accordingly, another aspect of the invention relates to a process for the preparation of hydroxymorpholone comprising a reaction step wherein the morphinone compound of formula III. is oxidized to a 1,4-hydroxynormorphone of formula IV. derivative. In particular, the method further comprises oxidizing the morphine derivative of formula II to a compound of formula I I I as described above. More particularly, a method of preparing hydroxyhydromorphone comprises the steps of: (a) morphine having formula I
經濟部智慧財產局8工消費舍作社印製 經由與式X 一 C ( = 〇) ORi (其中Ri如前述所定 義’且X爲鹵素(F、C1 、Br或I ,宜爲C1))所 示之鹵化甲酸酯進行反應,來使其轉化,再接著將其與 R2 - X (其中X (宜爲c 1 )和尺2如前述所義)反應, 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 1292761 Λ 1¾ 必1. A7 B7 五、發明説明() 5 以形成式I I之嗎啡衍生物; (b )根據前述方法,將式I I之嗎啡氧化,以形成 式I I I之嗎啡酮衍生物; (c )根據前述方法將式丨I丨之嗎啡酮衍生物氧化 ,以形成式I V之1 4 一羥基降嗎啡酮衍生物; (d )將式I V之1 4 一羥基降嗎啡酮衍生物在3 — 位置處去保護並(同時)將在7,8 -位置處之雙鍵還原 ’以形成式V之3,1 4 -羥基降嗎啡酮衍生物,此係利 用本領域中所熟知之用於這類反應的方法,如:使用氫和 鈀-碳做爲催化劑,來進行, (請先閱讀背面之注意事項再填寫本頁)The Ministry of Economic Affairs, the Intellectual Property Office, is printed by the X-C (= 〇) ORi (where Ri is as defined above and X is halogen (F, C1, Br or I, preferably C1)) The halogenated formate is reacted to convert it, and then reacted with R2 - X (where X (preferably c 1 ) and ruler 2 are as defined above). This paper scale applies to Chinese national standards. (CNS) A4 size (210X297 mm) 1292761 Λ 13⁄4 must 1. A7 B7 5. Inventive Note () 5 to form a morphine derivative of formula II; (b) oxidize morphine of formula II according to the aforementioned method to form a morphinone derivative of formula III; (c) oxidizing a morphinone derivative of the formula 根据I丨 according to the aforementioned method to form a 1,4-hydroxynormorphone derivative of the formula IV; (d) The monohydroxynormorphone derivative is deprotected at the 3-position and (simultaneously) reduces the double bond at the 7,8-position to form a 3,14-hydroxynormorphone derivative of formula V, which is Using methods well known in the art for such reactions, such as using hydrogen and palladium-carbon as catalysts, Read the notes on the back and fill out this page.)
經濟部智慧財產局員工消費合作社印製 (e )將式V之3,1 4 一羥基降嗎啡酮衍生物水解 成式V I之降羥二氫嗎啡酮,此係利用本領域中所熟知之 用於這類水解的方法(如:使用硫酸)來進行,Printed by the Intellectual Property Office of the Ministry of Economic Affairs, Employees' Consumption Cooperative (e) Hydrolysis of the 3,1 4-hydroxynormorphone derivative of Formula V to the hydroxydihydromorphone of Formula VI, which is well known in the art. For such hydrolysis methods (eg, using sulfuric acid),
在降羥二氫嗎啡酮之製備方法中,該式I I 、I I I 、和I V之新穎中間物彼此各形成本發明的一部分。其中 R i爲乙基之式I I、I I I和I V之中間物爲特別合適者 。其中R 2爲苄基之式I I、I I I和I v的中間物亦爲較 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) -8 - 1292761 a7 B7 __ 五、發明説明() 6 佳者。最佳的爲其中尺2爲乙基,R2爲苄基之式1 1 、 I I I和I V的中間物。 (請先閱讀背面之注意事項再填寫本頁) 本發明藉下列實施例來做進一步說明。 實施例1 具下加線之數字係指圖解I中之構造編號(Β η =苄 基)。 經濟部智慧財產局員工消費合作社印製 (5α,6α) 一 3 —(爷氯基)~ 7 ’ 8 -二脫氫一 4一 ,5 -環氣基一 6 -禪某嗎啡烷一 17 —羧酸乙酯(2__) 將嗎啡(1,8克)溶於8 0毫升甲苯中,並藉由水 之共沸蒸餾來乾燥此溶液。加入碳酸鈉(1 5克)和碳酸 氫鈉(6克),並再度藉由共沸蒸餾來乾燥此溶液。在 7 8 °C下,於約4小時之期間內,將氯甲酸乙酯(3 0克 )慢慢地,一部分一部分地加入其中。以T L C來檢查反 應是否完成。經由加入水來溶解過量之試劑和鹽類。將有 機和水溶液層分開,並以水清洗甲苯層。將甲苯溶液蒸發 至乾燥,並將殘質溶於7 0毫升乙醇中。在5 5 °C下,藉 6克氫氧化鉀(溶於1 8毫升乙醇中)和5克碳酸鉀來皂 化3 -羧酸乙酯基團。檢查pH値(在水中做1 : 1稀釋 )且其p Η係大於1 1。將5克苄基氯加入此鹼性溶液中 ,且在7 5 °C下,進行反應4小時。加入水(7 0毫升) 以沈澱出產物,過濾之,再以水清洗並乾燥之。產物(1 )之產量爲1 0克。 本纸張尺度適用中國國家標率(CNS ) A4規格(210X297公釐) -9- 1292761 五、發明説明(7) 1 H NMR (600MHz,CDC13) δ 1·29(ιώ,3Η),1.92( m,2H), 2 · 5 2 ( s,1 Η ),2 · 7 2 ( m,2 Η ), 2.85(m,lH),3.〇l(m,lH), 4- 01(m,lH),4.17( m,3H), 4.87 (d,lH),4.89(d,lH), 5- 09(d,lH),5.18(d,lH), 5.29(t,lH),5·72(ΐ,1Η), 6.53(d,lH),6.75(d,lH), 7 · 3 7 ( m,5 H )。 一(._5·. α) — 3 — (苄氣某)一7 ,8 —二脫氣一 4 ,·5 — 環_氣基一 6 -醌基嗎啡烷-1 7 -羧_ 7,酯(1) 經由將7 · 5克重鉻酸鈉· 2 Η 2 0溶於2 2毫升水和 6毫升硫酸中來製備瓊斯(】〇nes )試劑溶液。將化合物( U (7· 5克)溶於60毫升三氯乙烯中,並加入28 毫升水。以硫酸將p Η値調爲5。將混合物在回流下加熱 ,並在1小時的期間內,將瓊斯試劑慢慢加入其中,讓氧 化反應在回流下繼續進行1,5小時。以6毫升2 —丙醇 來破壞過量的氧化劑。將不同相分開,以1 〇 %碳酸氫鈉 和水清洗有機層,並以硫酸鈉乾燥之。將溶液蒸至乾燥, 並將殘質溶於乙醇中。產量:〜9克產物(U 。 1 H NMR(200MHz,CDC13) 5 1.28( m,3H) ,1.92( m,2H), 本纸張尺度適用中國國家標率(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) 訂 經濟部智慧財產局員工消費合作社印製 -10- 1292761 v ^ Δ7 私l A7 _ _ B7_ 五、發明説明(Q) ο 2 · 8 ( m,2 Η ) ,2 · 9 ( m,1 Η ), 3.05( m,lH) ,4.02( m,lH), 4.19( m,2H) ,4.72(s,lH), 5.03( m,1H) ,5.18(s,2H), 6.12(dd,lH) ,6.57(d,lH), 6.64( m,lH) ,6.74(d,lH), 7 · 3 4 ( n,5 H )。 (5α) — 3 -(苄氧基)—7,8 —二脫氫一4,5 — 環氧基—1 4 一羥基一 6 —酮基嗎啡烷一1 7 —羧酸乙酯 (1) 將在乙醇中之產物(D的溶液(9克,溶於1 3 5 毫升中)加熱至6 0 °C,加入2 . 6克醋酸鈷(I I ), 及0 · 5克醋酸鈉,並將空氣在劇烈攪拌下通氣下溶液中 。以T L C追踪反應。在反應完成後,以木炭(〇 . 3克 )處理溶液並過濾之。蒸餾該溶液,再將此濃縮溶液( 6 · 3克(U ,溶於5 3毫升乙醇中)轉移至下一步驟 中〇 ]H NMR of 4(360MHz,CH3〇H-d4)5 1.28(m,3H),1.55(m,lH), 2.52(m,lH) ,2.74(m,lH), 2.92( m,2H) ,4.05(m,lH), 4.15( m,2H) ,4.64( m,lH), 4.72(s,lH) ,4.85( m,lH), 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)In the process for the preparation of hydroxyhydromorphone, the novel intermediates of the formulae I I , I I I and IV each form part of the invention. An intermediate of the formula I I, I I I and I V wherein R i is ethyl is particularly suitable. The intermediates of formulas II, III and I v in which R 2 is a benzyl group are also applicable to the Chinese National Standard (CNS) A4 specification (210X 297 mm) -8 - 1292761 a7 B7 __. () 6 good. Most preferred are intermediates of formula 1 1 , I I I and I V wherein rule 2 is ethyl and R 2 is benzyl. (Please read the precautions on the back and then fill out this page.) The present invention is further illustrated by the following examples. Example 1 The number with the underlined line refers to the construction number (Β η = benzyl) in Scheme I. Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Cooperatives (5α, 6α) - 3 - (Ye chloro) ~ 7 ' 8 - didehydro- 4, 5- - ring-based 6 - Zen morphine - 17 - Ethyl Carboxylate (2__) Morphine (1,8 g) was dissolved in 80 ml of toluene and the solution was dried by azeotropic distillation of water. Sodium carbonate (15 g) and sodium hydrogencarbonate (6 g) were added, and the solution was again dried by azeotropic distillation. Ethyl chloroformate (30 g) was slowly and partially added thereto at 7 8 ° C over a period of about 4 hours. Check if the reaction is complete with T L C. Excess reagents and salts are dissolved by the addition of water. The organic and aqueous layers were separated and the toluene layer was washed with water. The toluene solution was evaporated to dryness and the residue was dissolved in 70 mL of ethanol. The 3-carboxylic acid ethyl ester group was saponified by 6 g of potassium hydroxide (dissolved in 18 ml of ethanol) and 5 g of potassium carbonate at 5 5 °C. Check pH 値 (diluted 1: 1 in water) and its p Η system is greater than 11. 5 g of benzyl chloride was added to the alkaline solution, and the reaction was carried out at 75 ° C for 4 hours. Water (70 ml) was added to precipitate the product, which was filtered, washed with water and dried. The yield of the product (1) was 10 g. This paper scale applies to China National Standard Rate (CNS) A4 specification (210X297 mm) -9- 1292761 V. Invention description (7) 1 H NMR (600MHz, CDC13) δ 1·29 (ιώ, 3Η), 1.92 ( m,2H), 2 · 5 2 ( s,1 Η ),2 · 7 2 ( m,2 Η ), 2.85(m,lH),3.〇l(m,lH), 4- 01(m, lH), 4.17( m,3H), 4.87 (d,lH),4.89(d,lH), 5- 09(d,lH), 5.18(d,lH), 5.29(t,lH),5·72 (ΐ, 1Η), 6.53(d,lH), 6.75(d,lH), 7 · 3 7 ( m,5 H ). One (._5·.α) — 3 — (Benzyl) a 7 , 8 — 2 degassing 4 , · 5 — Ring — gas — 6 — mercaptomorphin-1 7 —carboxy — 7, ester (1) A Jones (] 〇nes ) reagent solution was prepared by dissolving 7.5 g of sodium dichromate·2 Η 20 in 2 2 ml of water and 6 ml of sulfuric acid. The compound (U (7.5 g) was dissolved in 60 ml of trichloroethylene and 28 ml of water was added. The p Η値 was adjusted to 5 with sulfuric acid. The mixture was heated under reflux for a period of 1 hour. The Jones reagent was slowly added thereto, and the oxidation reaction was continued for 1.5 hours under reflux. The excess oxidant was destroyed with 6 ml of 2-propanol. The phases were separated, and the organic phase was washed with 1% by weight of sodium hydrogencarbonate and water. The layers were dried over sodium sulphate. The solution was evaporated to dryness and the residue was dissolved in ethanol. Yield: </ </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> ( m, 2H), the paper scale applies to China National Standard Rate (CNS) A4 specification (210X297 mm) (please read the notes on the back and fill out this page). Printed by the Ministry of Economic Affairs, Intellectual Property Bureau, Staff Consumer Cooperatives - 10- 1292761 v ^ Δ7 Private l A7 _ _ B7_ V. Description of invention (Q) ο 2 · 8 ( m,2 Η ) , 2 · 9 ( m,1 Η ), 3.05( m,lH) ,4.02( m , lH), 4.19( m,2H) , 4.72(s,lH), 5.03( m,1H) , 5.18(s,2H), 6.12(dd,lH) ,6.57(d,lH), 6.64( m, lH) , 6.74(d,lH), 7 · 3 4 ( n,5 H ) (5α) — 3 —(benzyloxy)-7,8 —didehydro-4,5—epoxy—1 4 Hydroxy-6-ketomorphinan-1-7-carboxylic acid ethyl ester (1) The product in ethanol (solution D (9 g, dissolved in 135 ml) was heated to 60 ° C, added 2 6 g of cobalt (II) acetate, and 0.5 g of sodium acetate, and the air was ventilated under vigorous stirring. The reaction was followed by TLC. After the reaction was completed, the solution was treated with charcoal (3 g). Filtration. Distill the solution and transfer the concentrated solution (6.3 g (U, dissolved in 53 ml of ethanol) to the next step] H NMR of 4 (360 MHz, CH3〇H-d4)5 1.28(m,3H), 1.55(m,lH), 2.52(m,lH), 2.74(m,lH), 2.92( m,2H) ,4.05(m,lH), 4.15( m,2H) ,4.64 ( m,lH), 4.72(s,lH) ,4.85( m,lH), the paper size applies to the Chinese National Standard (CNS) A4 specification (210X 297 mm) (please read the notes on the back and fill in the form) page)
、1T 經濟部智慧財產局員工消費合作社印製 -11 - 1292761 五、發明説明(9) 5.1(s,2H) ,6.05(d,lH), 6.6(d,lH) ,6.76(d,lH), 6 · 9 1 ( m,1 Η ) ,7 · 3 ( m,5 Η )。 (5α) - 4,5 -環氧基一 3 ,14 一二禪某一 6 —酮 基嗎啡烷—1 7 —羧酸乙酯(5^) 在先前步驟之溶液中加入6毫升醋酸。在2 0°C,正 常壓力下,以氫來還原產物(1),並以鈀一碳(5%) 做爲催化劑。過濾並蒸發乙醇後,可取得5 . 4克之粗產 物(5 )。將產物從2份(w / v )之醋酸乙酯中再結晶 出來,以取得4 · 7克之產物(且J 。 (5α) — 4,5 —環氣某一3 ,14-二羥基嗎啡烷一 6 —酮(降羥二氤嗎啡酮)(6_) 將產物(U ( 4 · 7克)溶於2 8毫升水和5 · 6 毫升硫酸中,並回流約2 4小時。將產物在ρ Η = 9下, 藉由水之稀釋來沈澱下來,過濾並乾燥後可取得4 · 6克 之粗產物(D 。將產物藉由溶解在乙醇中來純化,於 Ρ Η = 2下,將其從此溶劑中沈澱出來,將其於水中溶解 後,再以木炭處理之,並於ρ Η = 9下沈澱之。 1 H NMR (400MHz ,DMS〇 一 d6) 5 1.17(m,lH),1.41(m,lH), 1.72(m,lH),2.07( m,lH), 2.29( m,iH),2.36( m,lH), 本紙張尺度適用中國國家標準(CNS〉A4規格(210X 297公 (請先閱讀背面之注意事項再填寫本頁) Τ ¾齊印和曰达时產苟R工消費合作社印製 -12- 1292761 Δ7 A 7 Β7五、發明説明(& 2.62(m,lH),3.9(m,4H), 4.68(s,lH) ,6.52(d,lH), 6.56(d,lH)〇 圖解1 經濟部智慈財產局員工消費合作社印製, 1T Ministry of Economic Affairs Intellectual Property Bureau employee consumption cooperative printing -11 - 1292761 V. Invention description (9) 5.1 (s, 2H), 6.05 (d, lH), 6.6 (d, lH), 6.76 (d, lH) , 6 · 9 1 ( m,1 Η ) , 7 · 3 ( m,5 Η ). (5α) - 4,5-Epoxy- 3,14-II zen 6-ketomorphinan- 1 7-carboxylic acid ethyl ester (5^) 6 ml of acetic acid was added to the solution of the previous step. The product (1) was reduced with hydrogen at 20 ° C under normal pressure, and palladium-carbon (5%) was used as a catalyst. After filtering and evaporating the ethanol, 5.4 g of the crude product (5) was obtained. The product was recrystallized from 2 parts (w / v) of ethyl acetate to obtain 4 · 7 g of product (and J. (5α) - 4,5 - a certain 3,14-dihydroxymorphinane a 6-keto (hypoxanthone) (6_) The product (U (4 · 7 g) was dissolved in 28 ml of water and 5 · 6 ml of sulfuric acid and refluxed for about 24 hours. The product was in ρ Η = 9 , precipitated by dilution with water, filtered and dried to obtain 4 · 6 g of crude product (D. The product is purified by dissolving in ethanol, under Ρ Η = 2, from this Precipitated in a solvent, dissolved in water, treated with charcoal, and precipitated at ρ Η = 9. 1 H NMR (400 MHz, DMS 〇-d6) 5 1.17 (m, lH), 1.41 (m) , lH), 1.72 (m, lH), 2.07 ( m, lH), 2.29 ( m, iH), 2.36 ( m, lH), this paper scale applies to Chinese national standards (CNS > A4 specifications (210X 297 public (please Read the precautions on the back and fill out this page. Τ 3⁄4 齐印和曰达时 苟 R Industrial Consumer Cooperative Print -12- 1292761 Δ7 A 7 Β7 5, invention description (& 2.62 (m, lH), 3.9 (m, 4H), 4.68(s lH), 6.52 (d, lH), 6.56 (d, lH) Scheme 1 billion Ministry of Economic Affairs Chi Chi Property Office employees consumer cooperatives printed
(請先閲讀背面之注意事項再填寫本頁) 訂 本纸張尺度適用中國國家標準(CNS ) A4規格(210Χ 297公釐) -13-(Please read the notes on the back and fill out this page.) The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210Χ 297 mm) -13-
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW91115230A TWI292761B (en) | 2002-07-09 | 2002-07-09 | C-14 oxidation of morphine derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW91115230A TWI292761B (en) | 2002-07-09 | 2002-07-09 | C-14 oxidation of morphine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
TWI292761B true TWI292761B (en) | 2008-01-21 |
Family
ID=45067626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW91115230A TWI292761B (en) | 2002-07-09 | 2002-07-09 | C-14 oxidation of morphine derivatives |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI292761B (en) |
-
2002
- 2002-07-09 TW TW91115230A patent/TWI292761B/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7939543B2 (en) | Method of reducing α, β unsaturated ketones in opioid compositions | |
TW505648B (en) | Preparation of 14-hydroxynormorphinones, oxycodone noroxymorphone, oxymorphone and naltrexone from normorphinones | |
US8227609B2 (en) | Process for purifying noroxymorphone compounds | |
US6291675B1 (en) | Methods of o-demethylation and n-deprotection | |
US7405301B2 (en) | Chemical methods | |
JP4559730B2 (en) | Preparation method of 14-hydroxynormorphinone derivative. | |
US8236957B2 (en) | Process for making morphinan-6α-ols | |
SK3212004A3 (en) | Method of preparation oxycodone | |
AU2002331163A1 (en) | Process for the Preparation of a 14-hydroxynormorphinone Compound | |
EP2995614B1 (en) | Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof | |
US7348430B2 (en) | Production of opioid analgesics | |
AU2007267439B2 (en) | Process for the demethylation of oxycodone and related compounds | |
TWI292761B (en) | C-14 oxidation of morphine derivatives | |
KR100939347B1 (en) | Synthetic Method of optically pure S-3-hydroxypyrrolidine | |
WO2005012227A2 (en) | Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine | |
US6949645B1 (en) | Process for the production of opiates | |
US6972332B1 (en) | Process for the production of opiates | |
TW466236B (en) | Process for preparing aromatic ring-fused cyclopentane derivatives and intermediates used therein | |
US8093391B2 (en) | Process for the preparation of substantially pure palonosetron and its acid salts | |
EP3252055B1 (en) | Process for obtaining 3,14-diacetyloxymorphone from oripavine | |
JP2003321454A (en) | METHOD FOR PRODUCING 6-AMINOMETHYL-6,11-DIHYDRO-5H- DIBENZO[b,e]AZEPINE | |
JPH06206863A (en) | Diaminobipyrrole compound and its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |